Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02741999 · ClinicalTrials.gov registry record
A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early
A clinical trial, sponsored by Tufts Medical Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT02741999 is a clinical trial that has completed, run by Tufts Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT02741999 has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This protocol seeks to enroll smoldering multiple myeloma (SMM) and monoclonal gammopathy of undetermined significant (MGUS) patients with λ light chain (LC) involvement, a group of patients for whom standard of care is observation not treatment. Patients with SMM and MGUS have a precursor plasma cell disorder from which light chain amyloidosis (AL) can evolve. In this trial, enrolled subjects will have blood and if available bone marrow cells evaluated by molecular testing to determine their clonal λ LC variable region (VL) germline gene. Seventy percent of AL cases involve just 7 germline donors, 5 of which are λ germline donors. The hypothesis that will be tested with this protocol is that the presence of AL germline genes associated with AL in patients with a pre-existing diagnosis of λ SMM or λ MGUS indicates the presence of AL or risk of progression to AL.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-04-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02741999
The ClinicalTrials.gov registry entry for NCT02741999 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02741999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02741999 about?
NCT02741999 is a clinical study titled "A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early". This protocol seeks to enroll smoldering multiple myeloma (SMM) and monoclonal gammopathy of undetermined significant (MGUS) patients with λ light chain (LC) involvement, a group of patients for whom standard of care is observation not treatment. Patients with SMM and MGUS have a precursor plasma ce...
What is the current status of trial NCT02741999?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2016-04. Estimated completion is 2020-04-05.
Who is sponsoring clinical trial NCT02741999?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.